nodes	percent_of_prediction	percent_of_DWPC	metapath
Metformin—NDUFS7—Doxorubicin—kidney cancer	0.146	0.301	CbGbCtD
Metformin—NDUFS2—Doxorubicin—kidney cancer	0.146	0.301	CbGbCtD
Metformin—NDUFS3—Doxorubicin—kidney cancer	0.146	0.301	CbGbCtD
Metformin—SLC22A3—Vincristine—kidney cancer	0.0292	0.0601	CbGbCtD
Metformin—SLC22A2—Vinblastine—kidney cancer	0.0176	0.0362	CbGbCtD
Metformin—SLC22A2—nephron—kidney cancer	0.00182	0.0115	CbGeAlD
Metformin—NDUFS6—renal system—kidney cancer	0.00128	0.00807	CbGeAlD
Metformin—NDUFS4—Everolimus—Temsirolimus—kidney cancer	0.00126	0.24	CbGdCrCtD
Metformin—SLC29A4—renal system—kidney cancer	0.00119	0.00751	CbGeAlD
Metformin—NDUFAF3—renal system—kidney cancer	0.00116	0.00735	CbGeAlD
Metformin—SLC29A4—kidney—kidney cancer	0.00115	0.00726	CbGeAlD
Metformin—NDUFAF3—kidney—kidney cancer	0.00113	0.0071	CbGeAlD
Metformin—NDUFAF3—gonad—kidney cancer	0.00104	0.00659	CbGeAlD
Metformin—NDUFA9—renal system—kidney cancer	0.00104	0.00658	CbGeAlD
Metformin—NDUFA13—renal system—kidney cancer	0.00104	0.00658	CbGeAlD
Metformin—NDUFA1—renal system—kidney cancer	0.00103	0.00648	CbGeAlD
Metformin—NDUFA9—kidney—kidney cancer	0.00101	0.00636	CbGeAlD
Metformin—NDUFA13—kidney—kidney cancer	0.00101	0.00636	CbGeAlD
Metformin—NDUFV2—renal system—kidney cancer	0.000997	0.00629	CbGeAlD
Metformin—NDUFA1—kidney—kidney cancer	0.000993	0.00626	CbGeAlD
Metformin—NDUFV2—kidney—kidney cancer	0.000964	0.00608	CbGeAlD
Metformin—NDUFC1—Everolimus—Temsirolimus—kidney cancer	0.000957	0.182	CbGdCrCtD
Metformin—NDUFA9—Everolimus—Temsirolimus—kidney cancer	0.000957	0.182	CbGdCrCtD
Metformin—NDUFS2—Everolimus—Temsirolimus—kidney cancer	0.000957	0.182	CbGdCrCtD
Metformin—NDUFA2—nephron tubule—kidney cancer	0.000951	0.006	CbGeAlD
Metformin—NDUFA9—gonad—kidney cancer	0.000936	0.0059	CbGeAlD
Metformin—NDUFA13—gonad—kidney cancer	0.000936	0.0059	CbGeAlD
Metformin—ND4L—renal system—kidney cancer	0.000912	0.00575	CbGeAlD
Metformin—ND5—renal system—kidney cancer	0.000912	0.00575	CbGeAlD
Metformin—ND3—renal system—kidney cancer	0.000912	0.00575	CbGeAlD
Metformin—ND2—renal system—kidney cancer	0.000912	0.00575	CbGeAlD
Metformin—NDUFA10—nephron tubule—kidney cancer	0.000907	0.00572	CbGeAlD
Metformin—NDUFC1—nephron tubule—kidney cancer	0.000899	0.00567	CbGeAlD
Metformin—NDUFV2—gonad—kidney cancer	0.000894	0.00564	CbGeAlD
Metformin—NDUFB2—nephron tubule—kidney cancer	0.000892	0.00563	CbGeAlD
Metformin—NDUFAF1—nephron tubule—kidney cancer	0.000884	0.00558	CbGeAlD
Metformin—ND4—renal system—kidney cancer	0.000883	0.00557	CbGeAlD
Metformin—ND5—kidney—kidney cancer	0.000882	0.00556	CbGeAlD
Metformin—ND3—kidney—kidney cancer	0.000882	0.00556	CbGeAlD
Metformin—ND2—kidney—kidney cancer	0.000882	0.00556	CbGeAlD
Metformin—ND4L—kidney—kidney cancer	0.000882	0.00556	CbGeAlD
Metformin—NDUFB3—nephron tubule—kidney cancer	0.00087	0.00549	CbGeAlD
Metformin—NDUFA4L2—cardiac atrium—kidney cancer	0.000869	0.00548	CbGeAlD
Metformin—NDUFA2—renal system—kidney cancer	0.000865	0.00545	CbGeAlD
Metformin—ND4—kidney—kidney cancer	0.000853	0.00538	CbGeAlD
Metformin—NDUFB6—nephron tubule—kidney cancer	0.000844	0.00532	CbGeAlD
Metformin—NDUFAF4—nephron tubule—kidney cancer	0.000844	0.00532	CbGeAlD
Metformin—NDUFS1—nephron tubule—kidney cancer	0.000837	0.00528	CbGeAlD
Metformin—NDUFA2—kidney—kidney cancer	0.000836	0.00527	CbGeAlD
Metformin—NDUFB7—nephron tubule—kidney cancer	0.000825	0.00521	CbGeAlD
Metformin—NDUFA10—renal system—kidney cancer	0.000825	0.0052	CbGeAlD
Metformin—NDUFB1—nephron tubule—kidney cancer	0.00082	0.00517	CbGeAlD
Metformin—NDUFS8—nephron tubule—kidney cancer	0.00082	0.00517	CbGeAlD
Metformin—ND4L—gonad—kidney cancer	0.000818	0.00516	CbGeAlD
Metformin—ND5—gonad—kidney cancer	0.000818	0.00516	CbGeAlD
Metformin—ND3—gonad—kidney cancer	0.000818	0.00516	CbGeAlD
Metformin—ND2—gonad—kidney cancer	0.000818	0.00516	CbGeAlD
Metformin—NDUFA2—cortex of kidney—kidney cancer	0.000814	0.00514	CbGeAlD
Metformin—NDUFB2—renal system—kidney cancer	0.000811	0.00511	CbGeAlD
Metformin—NDUFB5—nephron tubule—kidney cancer	0.000809	0.0051	CbGeAlD
Metformin—NDUFA6—nephron tubule—kidney cancer	0.000809	0.0051	CbGeAlD
Metformin—NDUFAF1—renal system—kidney cancer	0.000804	0.00507	CbGeAlD
Metformin—NDUFS4—nephron tubule—kidney cancer	0.000803	0.00507	CbGeAlD
Metformin—NDUFA10—kidney—kidney cancer	0.000797	0.00503	CbGeAlD
Metformin—ND6—renal system—kidney cancer	0.000797	0.00503	CbGeAlD
Metformin—NDUFB4—nephron tubule—kidney cancer	0.000793	0.005	CbGeAlD
Metformin—ND4—gonad—kidney cancer	0.000791	0.00499	CbGeAlD
Metformin—NDUFB3—renal system—kidney cancer	0.000791	0.00499	CbGeAlD
Metformin—NDUFAB1—nephron tubule—kidney cancer	0.000788	0.00497	CbGeAlD
Metformin—NDUFB2—kidney—kidney cancer	0.000784	0.00494	CbGeAlD
Metformin—NDUFA8—nephron tubule—kidney cancer	0.000783	0.00494	CbGeAlD
Metformin—NDUFA4—nephron tubule—kidney cancer	0.000778	0.00491	CbGeAlD
Metformin—NDUFA10—cortex of kidney—kidney cancer	0.000777	0.0049	CbGeAlD
Metformin—NDUFA2—cardiac atrium—kidney cancer	0.000774	0.00488	CbGeAlD
Metformin—NDUFB11—nephron tubule—kidney cancer	0.000774	0.00488	CbGeAlD
Metformin—NDUFV1—nephron tubule—kidney cancer	0.000774	0.00488	CbGeAlD
Metformin—NDUFA5—renal system—kidney cancer	0.000773	0.00487	CbGeAlD
Metformin—NDUFA11—renal system—kidney cancer	0.000773	0.00487	CbGeAlD
Metformin—ND6—kidney—kidney cancer	0.000771	0.00486	CbGeAlD
Metformin—NDUFC1—cortex of kidney—kidney cancer	0.00077	0.00486	CbGeAlD
Metformin—NDUFS5—nephron tubule—kidney cancer	0.000769	0.00485	CbGeAlD
Metformin—NDUFB8—nephron tubule—kidney cancer	0.000769	0.00485	CbGeAlD
Metformin—NDUFB2—cortex of kidney—kidney cancer	0.000763	0.00481	CbGeAlD
Metformin—NDUFS1—renal system—kidney cancer	0.000761	0.0048	CbGeAlD
Metformin—NDUFAF1—cortex of kidney—kidney cancer	0.000757	0.00477	CbGeAlD
Metformin—NDUFB10—renal system—kidney cancer	0.000756	0.00477	CbGeAlD
Metformin—NDUFA12—renal system—kidney cancer	0.00075	0.00473	CbGeAlD
Metformin—NDUFB7—renal system—kidney cancer	0.00075	0.00473	CbGeAlD
Metformin—NDUFA5—kidney—kidney cancer	0.000747	0.00471	CbGeAlD
Metformin—NDUFA11—kidney—kidney cancer	0.000747	0.00471	CbGeAlD
Metformin—NDUFS8—renal system—kidney cancer	0.000745	0.0047	CbGeAlD
Metformin—NDUFB1—renal system—kidney cancer	0.000745	0.0047	CbGeAlD
Metformin—NDUFAF2—cortex of kidney—kidney cancer	0.000745	0.0047	CbGeAlD
Metformin—NDUFB3—cortex of kidney—kidney cancer	0.000745	0.0047	CbGeAlD
Metformin—NDUFA10—gonad—kidney cancer	0.00074	0.00467	CbGeAlD
Metformin—NDUFS1—kidney—kidney cancer	0.000736	0.00464	CbGeAlD
Metformin—NDUFB5—renal system—kidney cancer	0.000735	0.00464	CbGeAlD
Metformin—NDUFA6—renal system—kidney cancer	0.000735	0.00464	CbGeAlD
Metformin—NDUFC1—cardiac atrium—kidney cancer	0.000732	0.00462	CbGeAlD
Metformin—NDUFB10—kidney—kidney cancer	0.000731	0.00461	CbGeAlD
Metformin—NDUFS4—renal system—kidney cancer	0.00073	0.00461	CbGeAlD
Metformin—NDUFA5—cortex of kidney—kidney cancer	0.000727	0.00459	CbGeAlD
Metformin—NDUFA11—cortex of kidney—kidney cancer	0.000727	0.00459	CbGeAlD
Metformin—NDUFB2—gonad—kidney cancer	0.000727	0.00459	CbGeAlD
Metformin—NDUFB7—kidney—kidney cancer	0.000725	0.00458	CbGeAlD
Metformin—NDUFA12—kidney—kidney cancer	0.000725	0.00458	CbGeAlD
Metformin—NDUFAF4—cortex of kidney—kidney cancer	0.000722	0.00455	CbGeAlD
Metformin—NDUFB6—cortex of kidney—kidney cancer	0.000722	0.00455	CbGeAlD
Metformin—NDUFB4—renal system—kidney cancer	0.000721	0.00455	CbGeAlD
Metformin—NDUFS7—nephron tubule—kidney cancer	0.000721	0.00455	CbGeAlD
Metformin—NDUFB1—kidney—kidney cancer	0.00072	0.00454	CbGeAlD
Metformin—NDUFS8—kidney—kidney cancer	0.00072	0.00454	CbGeAlD
Metformin—NDUFAF1—cardiac atrium—kidney cancer	0.00072	0.00454	CbGeAlD
Metformin—NDUFS1—cortex of kidney—kidney cancer	0.000717	0.00452	CbGeAlD
Metformin—NDUFAB1—renal system—kidney cancer	0.000716	0.00452	CbGeAlD
Metformin—ND6—gonad—kidney cancer	0.000715	0.00451	CbGeAlD
Metformin—NDUFB9—renal system—kidney cancer	0.000712	0.00449	CbGeAlD
Metformin—NDUFA8—renal system—kidney cancer	0.000712	0.00449	CbGeAlD
Metformin—NDUFB10—cortex of kidney—kidney cancer	0.000712	0.00449	CbGeAlD
Metformin—NDUFA6—kidney—kidney cancer	0.000711	0.00448	CbGeAlD
Metformin—NDUFB5—kidney—kidney cancer	0.000711	0.00448	CbGeAlD
Metformin—NDUFB3—gonad—kidney cancer	0.000709	0.00447	CbGeAlD
Metformin—NDUFB3—cardiac atrium—kidney cancer	0.000708	0.00447	CbGeAlD
Metformin—NDUFAF2—cardiac atrium—kidney cancer	0.000708	0.00447	CbGeAlD
Metformin—NDUFA4—renal system—kidney cancer	0.000708	0.00446	CbGeAlD
Metformin—NDUFA12—cortex of kidney—kidney cancer	0.000707	0.00446	CbGeAlD
Metformin—NDUFB7—cortex of kidney—kidney cancer	0.000707	0.00446	CbGeAlD
Metformin—NDUFB11—renal system—kidney cancer	0.000703	0.00444	CbGeAlD
Metformin—NDUFV1—renal system—kidney cancer	0.000703	0.00444	CbGeAlD
Metformin—NDUFB1—cortex of kidney—kidney cancer	0.000702	0.00443	CbGeAlD
Metformin—NDUFS8—cortex of kidney—kidney cancer	0.000702	0.00443	CbGeAlD
Metformin—NDUFS5—renal system—kidney cancer	0.000699	0.00441	CbGeAlD
Metformin—NDUFB8—renal system—kidney cancer	0.000699	0.00441	CbGeAlD
Metformin—NDUFB4—kidney—kidney cancer	0.000697	0.0044	CbGeAlD
Metformin—NDUFA5—gonad—kidney cancer	0.000693	0.00437	CbGeAlD
Metformin—NDUFAB1—kidney—kidney cancer	0.000693	0.00437	CbGeAlD
Metformin—NDUFB5—cortex of kidney—kidney cancer	0.000692	0.00437	CbGeAlD
Metformin—NDUFA6—cortex of kidney—kidney cancer	0.000692	0.00437	CbGeAlD
Metformin—NDUFA11—cardiac atrium—kidney cancer	0.000692	0.00436	CbGeAlD
Metformin—NDUFB9—kidney—kidney cancer	0.000688	0.00434	CbGeAlD
Metformin—NDUFA8—kidney—kidney cancer	0.000688	0.00434	CbGeAlD
Metformin—NDUFS4—cortex of kidney—kidney cancer	0.000688	0.00434	CbGeAlD
Metformin—NDUFAF4—cardiac atrium—kidney cancer	0.000687	0.00433	CbGeAlD
Metformin—NDUFB6—cardiac atrium—kidney cancer	0.000687	0.00433	CbGeAlD
Metformin—NDUFA4—kidney—kidney cancer	0.000684	0.00432	CbGeAlD
Metformin—NDUFS1—gonad—kidney cancer	0.000683	0.00431	CbGeAlD
Metformin—NDUFS1—cardiac atrium—kidney cancer	0.000682	0.0043	CbGeAlD
Metformin—NDUFV1—kidney—kidney cancer	0.00068	0.00429	CbGeAlD
Metformin—NDUFB11—kidney—kidney cancer	0.00068	0.00429	CbGeAlD
Metformin—NDUFB4—cortex of kidney—kidney cancer	0.000679	0.00428	CbGeAlD
Metformin—NDUFB10—gonad—kidney cancer	0.000678	0.00428	CbGeAlD
Metformin—NDUFB10—cardiac atrium—kidney cancer	0.000677	0.00427	CbGeAlD
Metformin—NDUFS5—kidney—kidney cancer	0.000676	0.00426	CbGeAlD
Metformin—NDUFB8—kidney—kidney cancer	0.000676	0.00426	CbGeAlD
Metformin—NDUFAB1—cortex of kidney—kidney cancer	0.000675	0.00426	CbGeAlD
Metformin—NDUFB7—gonad—kidney cancer	0.000673	0.00425	CbGeAlD
Metformin—NDUFA12—cardiac atrium—kidney cancer	0.000672	0.00424	CbGeAlD
Metformin—NDUFB7—cardiac atrium—kidney cancer	0.000672	0.00424	CbGeAlD
Metformin—NDUFA8—cortex of kidney—kidney cancer	0.00067	0.00423	CbGeAlD
Metformin—NDUFB9—cortex of kidney—kidney cancer	0.00067	0.00423	CbGeAlD
Metformin—NDUFB1—cardiac atrium—kidney cancer	0.000667	0.00421	CbGeAlD
Metformin—NDUFS8—cardiac atrium—kidney cancer	0.000667	0.00421	CbGeAlD
Metformin—NDUFA4—cortex of kidney—kidney cancer	0.000666	0.0042	CbGeAlD
Metformin—NDUFV1—cortex of kidney—kidney cancer	0.000662	0.00418	CbGeAlD
Metformin—NDUFB11—cortex of kidney—kidney cancer	0.000662	0.00418	CbGeAlD
Metformin—PRKAB1—nephron tubule—kidney cancer	0.000659	0.00416	CbGeAlD
Metformin—NDUFB5—gonad—kidney cancer	0.000659	0.00416	CbGeAlD
Metformin—NDUFA6—gonad—kidney cancer	0.000659	0.00416	CbGeAlD
Metformin—NDUFB5—cardiac atrium—kidney cancer	0.000658	0.00415	CbGeAlD
Metformin—NDUFA6—cardiac atrium—kidney cancer	0.000658	0.00415	CbGeAlD
Metformin—NDUFB8—cortex of kidney—kidney cancer	0.000658	0.00415	CbGeAlD
Metformin—NDUFS5—cortex of kidney—kidney cancer	0.000658	0.00415	CbGeAlD
Metformin—NDUFS7—renal system—kidney cancer	0.000655	0.00413	CbGeAlD
Metformin—NDUFS4—cardiac atrium—kidney cancer	0.000654	0.00413	CbGeAlD
Metformin—NDUFB4—gonad—kidney cancer	0.000647	0.00408	CbGeAlD
Metformin—NDUFB4—cardiac atrium—kidney cancer	0.000646	0.00407	CbGeAlD
Metformin—NDUFAB1—gonad—kidney cancer	0.000642	0.00405	CbGeAlD
Metformin—NDUFAB1—cardiac atrium—kidney cancer	0.000642	0.00405	CbGeAlD
Metformin—NDUFB9—gonad—kidney cancer	0.000638	0.00403	CbGeAlD
Metformin—NDUFA8—gonad—kidney cancer	0.000638	0.00403	CbGeAlD
Metformin—NDUFB9—cardiac atrium—kidney cancer	0.000638	0.00402	CbGeAlD
Metformin—NDUFA8—cardiac atrium—kidney cancer	0.000638	0.00402	CbGeAlD
Metformin—NDUFA4—cardiac atrium—kidney cancer	0.000634	0.004	CbGeAlD
Metformin—NDUFS7—kidney—kidney cancer	0.000633	0.004	CbGeAlD
Metformin—NDUFV1—gonad—kidney cancer	0.000631	0.00398	CbGeAlD
Metformin—NDUFB11—cardiac atrium—kidney cancer	0.00063	0.00397	CbGeAlD
Metformin—NDUFV1—cardiac atrium—kidney cancer	0.00063	0.00397	CbGeAlD
Metformin—NDUFS5—gonad—kidney cancer	0.000627	0.00396	CbGeAlD
Metformin—NDUFB8—gonad—kidney cancer	0.000627	0.00396	CbGeAlD
Metformin—NDUFS5—cardiac atrium—kidney cancer	0.000626	0.00395	CbGeAlD
Metformin—NDUFB8—cardiac atrium—kidney cancer	0.000626	0.00395	CbGeAlD
Metformin—NDUFS7—cortex of kidney—kidney cancer	0.000617	0.00389	CbGeAlD
Metformin—PRKAB1—renal system—kidney cancer	0.000599	0.00378	CbGeAlD
Metformin—NDUFS2—nephron tubule—kidney cancer	0.000597	0.00377	CbGeAlD
Metformin—NDUFS3—nephron tubule—kidney cancer	0.00059	0.00372	CbGeAlD
Metformin—NDUFS7—cardiac atrium—kidney cancer	0.000587	0.0037	CbGeAlD
Metformin—PRKAB1—kidney—kidney cancer	0.000579	0.00365	CbGeAlD
Metformin—NDUFC2—renal system—kidney cancer	0.000565	0.00356	CbGeAlD
Metformin—PRKAB1—cortex of kidney—kidney cancer	0.000564	0.00356	CbGeAlD
Metformin—NDUFC2—kidney—kidney cancer	0.000546	0.00344	CbGeAlD
Metformin—NDUFS2—renal system—kidney cancer	0.000543	0.00343	CbGeAlD
Metformin—PRKAB1—gonad—kidney cancer	0.000537	0.00339	CbGeAlD
Metformin—NDUFS3—renal system—kidney cancer	0.000536	0.00338	CbGeAlD
Metformin—NDUFC2—cortex of kidney—kidney cancer	0.000532	0.00335	CbGeAlD
Metformin—NDUFS2—kidney—kidney cancer	0.000525	0.00331	CbGeAlD
Metformin—NDUFS3—kidney—kidney cancer	0.000518	0.00327	CbGeAlD
Metformin—NDUFS2—cortex of kidney—kidney cancer	0.000511	0.00322	CbGeAlD
Metformin—NDUFC2—gonad—kidney cancer	0.000506	0.00319	CbGeAlD
Metformin—NDUFC2—cardiac atrium—kidney cancer	0.000506	0.00319	CbGeAlD
Metformin—NDUFS3—cortex of kidney—kidney cancer	0.000505	0.00319	CbGeAlD
Metformin—NDUFS2—gonad—kidney cancer	0.000487	0.00307	CbGeAlD
Metformin—NDUFS2—cardiac atrium—kidney cancer	0.000486	0.00307	CbGeAlD
Metformin—NDUFS3—gonad—kidney cancer	0.000481	0.00303	CbGeAlD
Metformin—NDUFS3—cardiac atrium—kidney cancer	0.00048	0.00303	CbGeAlD
Metformin—NDUFA2—Vincristine—Vinblastine—kidney cancer	0.000465	0.0882	CbGdCrCtD
Metformin—ND1—renal system—kidney cancer	0.000445	0.00281	CbGeAlD
Metformin—ND1—kidney—kidney cancer	0.000431	0.00272	CbGeAlD
Metformin—ND1—gonad—kidney cancer	0.000399	0.00252	CbGeAlD
Metformin—SLC22A2—nephron tubule—kidney cancer	0.000393	0.00248	CbGeAlD
Metformin—SLC22A2—renal system—kidney cancer	0.000357	0.00225	CbGeAlD
Metformin—SLC22A2—kidney—kidney cancer	0.000346	0.00218	CbGeAlD
Metformin—SLC22A2—cortex of kidney—kidney cancer	0.000337	0.00212	CbGeAlD
Metformin—SLC47A1—nephron tubule—kidney cancer	0.000333	0.0021	CbGeAlD
Metformin—SLC47A1—renal system—kidney cancer	0.000303	0.00191	CbGeAlD
Metformin—SLC47A1—kidney—kidney cancer	0.000293	0.00185	CbGeAlD
Metformin—SLC47A1—cortex of kidney—kidney cancer	0.000285	0.0018	CbGeAlD
Metformin—SLC47A1—gonad—kidney cancer	0.000271	0.00171	CbGeAlD
Metformin—NDUFA7—Azacitidine—Gemcitabine—kidney cancer	0.000257	0.0489	CbGdCrCtD
Metformin—SLC22A1—renal system—kidney cancer	0.000252	0.00159	CbGeAlD
Metformin—SLC22A1—kidney—kidney cancer	0.000244	0.00154	CbGeAlD
Metformin—SLC22A3—renal system—kidney cancer	0.000241	0.00152	CbGeAlD
Metformin—SLC22A3—kidney—kidney cancer	0.000233	0.00147	CbGeAlD
Metformin—NDUFA2—Azacitidine—Gemcitabine—kidney cancer	0.000219	0.0416	CbGdCrCtD
Metformin—SLC22A3—gonad—kidney cancer	0.000216	0.00137	CbGeAlD
Metformin—NDUFB3—Azacitidine—Gemcitabine—kidney cancer	0.000195	0.037	CbGdCrCtD
Metformin—Anorexia—Gemcitabine—kidney cancer	0.000127	0.000735	CcSEcCtD
Metformin—Oedema peripheral—Capecitabine—kidney cancer	0.000126	0.000734	CcSEcCtD
Metformin—Vomiting—Vinblastine—kidney cancer	0.000126	0.000734	CcSEcCtD
Metformin—Dizziness—Erlotinib—kidney cancer	0.000126	0.000734	CcSEcCtD
Metformin—Ill-defined disorder—Paclitaxel—kidney cancer	0.000126	0.000734	CcSEcCtD
Metformin—Connective tissue disorder—Capecitabine—kidney cancer	0.000126	0.000732	CcSEcCtD
Metformin—Vomiting—Everolimus—kidney cancer	0.000126	0.000731	CcSEcCtD
Metformin—Renal impairment—Doxorubicin—kidney cancer	0.000126	0.00073	CcSEcCtD
Metformin—Paraesthesia—Vincristine—kidney cancer	0.000126	0.00073	CcSEcCtD
Metformin—Rash—Everolimus—kidney cancer	0.000125	0.000725	CcSEcCtD
Metformin—Dermatitis—Everolimus—kidney cancer	0.000125	0.000724	CcSEcCtD
Metformin—Headache—Vinblastine—kidney cancer	0.000125	0.000723	CcSEcCtD
Metformin—Headache—Everolimus—kidney cancer	0.000124	0.00072	CcSEcCtD
Metformin—Hypotension—Gemcitabine—kidney cancer	0.000124	0.00072	CcSEcCtD
Metformin—Abdominal pain—Dactinomycin—kidney cancer	0.000124	0.000719	CcSEcCtD
Metformin—Asthenia—Sorafenib—kidney cancer	0.000123	0.000716	CcSEcCtD
Metformin—Malaise—Paclitaxel—kidney cancer	0.000123	0.000713	CcSEcCtD
Metformin—Hypoglycaemia—Doxorubicin—kidney cancer	0.000123	0.000712	CcSEcCtD
Metformin—Syncope—Paclitaxel—kidney cancer	0.000122	0.000709	CcSEcCtD
Metformin—Lethargy—Doxorubicin—kidney cancer	0.000122	0.000709	CcSEcCtD
Metformin—Decreased appetite—Vincristine—kidney cancer	0.000122	0.000706	CcSEcCtD
Metformin—Pruritus—Sorafenib—kidney cancer	0.000122	0.000706	CcSEcCtD
Metformin—Vomiting—Erlotinib—kidney cancer	0.000122	0.000705	CcSEcCtD
Metformin—Musculoskeletal discomfort—Gemcitabine—kidney cancer	0.000121	0.000702	CcSEcCtD
Metformin—Gastrointestinal disorder—Vincristine—kidney cancer	0.000121	0.000701	CcSEcCtD
Metformin—Fatigue—Vincristine—kidney cancer	0.000121	0.0007	CcSEcCtD
Metformin—Rash—Erlotinib—kidney cancer	0.000121	0.0007	CcSEcCtD
Metformin—Dermatitis—Erlotinib—kidney cancer	0.00012	0.000699	CcSEcCtD
Metformin—Palpitations—Paclitaxel—kidney cancer	0.00012	0.000699	CcSEcCtD
Metformin—Eye disorder—Capecitabine—kidney cancer	0.00012	0.000697	CcSEcCtD
Metformin—Headache—Erlotinib—kidney cancer	0.00012	0.000695	CcSEcCtD
Metformin—Loss of consciousness—Paclitaxel—kidney cancer	0.00012	0.000695	CcSEcCtD
Metformin—Constipation—Vincristine—kidney cancer	0.00012	0.000695	CcSEcCtD
Metformin—Pain in extremity—Doxorubicin—kidney cancer	0.00012	0.000694	CcSEcCtD
Metformin—Paraesthesia—Gemcitabine—kidney cancer	0.000119	0.000692	CcSEcCtD
Metformin—Flushing—Capecitabine—kidney cancer	0.000119	0.000692	CcSEcCtD
Metformin—Cardiac disorder—Capecitabine—kidney cancer	0.000119	0.000692	CcSEcCtD
Metformin—Asthenia—Sunitinib—kidney cancer	0.000119	0.000689	CcSEcCtD
Metformin—Dyspnoea—Gemcitabine—kidney cancer	0.000118	0.000687	CcSEcCtD
Metformin—Nausea—Vinblastine—kidney cancer	0.000118	0.000686	CcSEcCtD
Metformin—Somnolence—Gemcitabine—kidney cancer	0.000118	0.000685	CcSEcCtD
Metformin—Migraine—Doxorubicin—kidney cancer	0.000118	0.000684	CcSEcCtD
Metformin—Nausea—Everolimus—kidney cancer	0.000118	0.000683	CcSEcCtD
Metformin—Diarrhoea—Sorafenib—kidney cancer	0.000118	0.000683	CcSEcCtD
Metformin—Hypertension—Paclitaxel—kidney cancer	0.000118	0.000683	CcSEcCtD
Metformin—Pruritus—Sunitinib—kidney cancer	0.000117	0.00068	CcSEcCtD
Metformin—Angiopathy—Capecitabine—kidney cancer	0.000116	0.000676	CcSEcCtD
Metformin—Immune system disorder—Capecitabine—kidney cancer	0.000116	0.000673	CcSEcCtD
Metformin—Chest pain—Paclitaxel—kidney cancer	0.000116	0.000673	CcSEcCtD
Metformin—Myalgia—Paclitaxel—kidney cancer	0.000116	0.000673	CcSEcCtD
Metformin—Mediastinal disorder—Capecitabine—kidney cancer	0.000116	0.000672	CcSEcCtD
Metformin—Decreased appetite—Gemcitabine—kidney cancer	0.000115	0.00067	CcSEcCtD
Metformin—Chills—Capecitabine—kidney cancer	0.000115	0.000669	CcSEcCtD
Metformin—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	0.000115	0.000668	CcSEcCtD
Metformin—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.000115	0.000665	CcSEcCtD
Metformin—Discomfort—Paclitaxel—kidney cancer	0.000115	0.000665	CcSEcCtD
Metformin—Fatigue—Gemcitabine—kidney cancer	0.000114	0.000664	CcSEcCtD
Metformin—Gastrointestinal pain—Vincristine—kidney cancer	0.000114	0.000664	CcSEcCtD
Metformin—Dizziness—Sorafenib—kidney cancer	0.000114	0.00066	CcSEcCtD
Metformin—Constipation—Gemcitabine—kidney cancer	0.000114	0.000659	CcSEcCtD
Metformin—Nausea—Erlotinib—kidney cancer	0.000114	0.000659	CcSEcCtD
Metformin—Diarrhoea—Sunitinib—kidney cancer	0.000113	0.000657	CcSEcCtD
Metformin—Asthenia—Dactinomycin—kidney cancer	0.000112	0.000652	CcSEcCtD
Metformin—Erythema—Capecitabine—kidney cancer	0.000112	0.000649	CcSEcCtD
Metformin—Malnutrition—Capecitabine—kidney cancer	0.000112	0.000649	CcSEcCtD
Metformin—Dehydration—Doxorubicin—kidney cancer	0.000111	0.000646	CcSEcCtD
Metformin—Oedema—Paclitaxel—kidney cancer	0.000111	0.000645	CcSEcCtD
Metformin—Abdominal pain—Vincristine—kidney cancer	0.000111	0.000642	CcSEcCtD
Metformin—Liver function test abnormal—Doxorubicin—kidney cancer	0.00011	0.000641	CcSEcCtD
Metformin—Infection—Paclitaxel—kidney cancer	0.00011	0.000641	CcSEcCtD
Metformin—Flatulence—Capecitabine—kidney cancer	0.00011	0.000639	CcSEcCtD
Metformin—Dysgeusia—Capecitabine—kidney cancer	0.000109	0.000635	CcSEcCtD
Metformin—Dizziness—Sunitinib—kidney cancer	0.000109	0.000635	CcSEcCtD
Metformin—Feeling abnormal—Gemcitabine—kidney cancer	0.000109	0.000635	CcSEcCtD
Metformin—Shock—Paclitaxel—kidney cancer	0.000109	0.000635	CcSEcCtD
Metformin—Vomiting—Sorafenib—kidney cancer	0.000109	0.000635	CcSEcCtD
Metformin—Abdominal pain upper—Doxorubicin—kidney cancer	0.000109	0.000634	CcSEcCtD
Metformin—Nervous system disorder—Paclitaxel—kidney cancer	0.000109	0.000633	CcSEcCtD
Metformin—Thrombocytopenia—Paclitaxel—kidney cancer	0.000109	0.000632	CcSEcCtD
Metformin—Rash—Sorafenib—kidney cancer	0.000108	0.000629	CcSEcCtD
Metformin—Dermatitis—Sorafenib—kidney cancer	0.000108	0.000629	CcSEcCtD
Metformin—Breast disorder—Doxorubicin—kidney cancer	0.000108	0.000628	CcSEcCtD
Metformin—Skin disorder—Paclitaxel—kidney cancer	0.000108	0.000627	CcSEcCtD
Metformin—Headache—Sorafenib—kidney cancer	0.000108	0.000625	CcSEcCtD
Metformin—Muscle spasms—Capecitabine—kidney cancer	0.000107	0.000624	CcSEcCtD
Metformin—Hyperhidrosis—Paclitaxel—kidney cancer	0.000107	0.000624	CcSEcCtD
Metformin—Diarrhoea—Dactinomycin—kidney cancer	0.000107	0.000622	CcSEcCtD
Metformin—Nasopharyngitis—Doxorubicin—kidney cancer	0.000107	0.000621	CcSEcCtD
Metformin—Anorexia—Paclitaxel—kidney cancer	0.000106	0.000615	CcSEcCtD
Metformin—Vision blurred—Capecitabine—kidney cancer	0.000105	0.000611	CcSEcCtD
Metformin—Vomiting—Sunitinib—kidney cancer	0.000105	0.000611	CcSEcCtD
Metformin—Tremor—Capecitabine—kidney cancer	0.000105	0.000608	CcSEcCtD
Metformin—Rash—Sunitinib—kidney cancer	0.000104	0.000606	CcSEcCtD
Metformin—Dermatitis—Sunitinib—kidney cancer	0.000104	0.000605	CcSEcCtD
Metformin—Abdominal distension—Doxorubicin—kidney cancer	0.000104	0.000604	CcSEcCtD
Metformin—Hypotension—Paclitaxel—kidney cancer	0.000104	0.000603	CcSEcCtD
Metformin—Ill-defined disorder—Capecitabine—kidney cancer	0.000104	0.000602	CcSEcCtD
Metformin—Headache—Sunitinib—kidney cancer	0.000104	0.000602	CcSEcCtD
Metformin—Influenza—Doxorubicin—kidney cancer	0.000103	0.0006	CcSEcCtD
Metformin—Nausea—Sorafenib—kidney cancer	0.000102	0.000593	CcSEcCtD
Metformin—Pancreatitis—Doxorubicin—kidney cancer	0.000101	0.000588	CcSEcCtD
Metformin—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.000101	0.000588	CcSEcCtD
Metformin—Malaise—Capecitabine—kidney cancer	0.000101	0.000585	CcSEcCtD
Metformin—Angina pectoris—Doxorubicin—kidney cancer	0.000101	0.000585	CcSEcCtD
Metformin—Asthenia—Vincristine—kidney cancer	0.0001	0.000583	CcSEcCtD
Metformin—Syncope—Capecitabine—kidney cancer	0.0001	0.000582	CcSEcCtD
Metformin—Paraesthesia—Paclitaxel—kidney cancer	9.98e-05	0.000579	CcSEcCtD
Metformin—Vomiting—Dactinomycin—kidney cancer	9.96e-05	0.000578	CcSEcCtD
Metformin—Dyspnoea—Paclitaxel—kidney cancer	9.91e-05	0.000575	CcSEcCtD
Metformin—Somnolence—Paclitaxel—kidney cancer	9.88e-05	0.000574	CcSEcCtD
Metformin—Palpitations—Capecitabine—kidney cancer	9.88e-05	0.000573	CcSEcCtD
Metformin—Rash—Dactinomycin—kidney cancer	9.88e-05	0.000573	CcSEcCtD
Metformin—Nausea—Sunitinib—kidney cancer	9.83e-05	0.000571	CcSEcCtD
Metformin—Loss of consciousness—Capecitabine—kidney cancer	9.82e-05	0.00057	CcSEcCtD
Metformin—Dyspepsia—Paclitaxel—kidney cancer	9.78e-05	0.000568	CcSEcCtD
Metformin—Neutropenia—Doxorubicin—kidney cancer	9.67e-05	0.000561	CcSEcCtD
Metformin—Decreased appetite—Paclitaxel—kidney cancer	9.66e-05	0.000561	CcSEcCtD
Metformin—Hypertension—Capecitabine—kidney cancer	9.65e-05	0.00056	CcSEcCtD
Metformin—Upper respiratory tract infection—Doxorubicin—kidney cancer	9.61e-05	0.000558	CcSEcCtD
Metformin—Gastrointestinal disorder—Paclitaxel—kidney cancer	9.6e-05	0.000557	CcSEcCtD
Metformin—Fatigue—Paclitaxel—kidney cancer	9.58e-05	0.000556	CcSEcCtD
Metformin—Diarrhoea—Vincristine—kidney cancer	9.58e-05	0.000556	CcSEcCtD
Metformin—Asthenia—Gemcitabine—kidney cancer	9.53e-05	0.000553	CcSEcCtD
Metformin—Chest pain—Capecitabine—kidney cancer	9.52e-05	0.000552	CcSEcCtD
Metformin—Myalgia—Capecitabine—kidney cancer	9.52e-05	0.000552	CcSEcCtD
Metformin—Constipation—Paclitaxel—kidney cancer	9.51e-05	0.000552	CcSEcCtD
Metformin—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	9.45e-05	0.000549	CcSEcCtD
Metformin—Discomfort—Capecitabine—kidney cancer	9.4e-05	0.000546	CcSEcCtD
Metformin—Pruritus—Gemcitabine—kidney cancer	9.39e-05	0.000545	CcSEcCtD
Metformin—Nausea—Dactinomycin—kidney cancer	9.3e-05	0.00054	CcSEcCtD
Metformin—Dizziness—Vincristine—kidney cancer	9.25e-05	0.000537	CcSEcCtD
Metformin—Infestation NOS—Doxorubicin—kidney cancer	9.22e-05	0.000535	CcSEcCtD
Metformin—Drowsiness—Doxorubicin—kidney cancer	9.22e-05	0.000535	CcSEcCtD
Metformin—Infestation—Doxorubicin—kidney cancer	9.22e-05	0.000535	CcSEcCtD
Metformin—Feeling abnormal—Paclitaxel—kidney cancer	9.16e-05	0.000532	CcSEcCtD
Metformin—Oedema—Capecitabine—kidney cancer	9.12e-05	0.00053	CcSEcCtD
Metformin—Gastrointestinal pain—Paclitaxel—kidney cancer	9.09e-05	0.000528	CcSEcCtD
Metformin—Diarrhoea—Gemcitabine—kidney cancer	9.08e-05	0.000527	CcSEcCtD
Metformin—Infection—Capecitabine—kidney cancer	9.06e-05	0.000526	CcSEcCtD
Metformin—Neuropathy peripheral—Doxorubicin—kidney cancer	9.04e-05	0.000525	CcSEcCtD
Metformin—Shock—Capecitabine—kidney cancer	8.97e-05	0.000521	CcSEcCtD
Metformin—Nervous system disorder—Capecitabine—kidney cancer	8.95e-05	0.000519	CcSEcCtD
Metformin—Thrombocytopenia—Capecitabine—kidney cancer	8.93e-05	0.000518	CcSEcCtD
Metformin—Vomiting—Vincristine—kidney cancer	8.9e-05	0.000517	CcSEcCtD
Metformin—Skin disorder—Capecitabine—kidney cancer	8.86e-05	0.000514	CcSEcCtD
Metformin—Urticaria—Paclitaxel—kidney cancer	8.83e-05	0.000513	CcSEcCtD
Metformin—Rash—Vincristine—kidney cancer	8.82e-05	0.000512	CcSEcCtD
Metformin—Hyperhidrosis—Capecitabine—kidney cancer	8.82e-05	0.000512	CcSEcCtD
Metformin—Dermatitis—Vincristine—kidney cancer	8.82e-05	0.000512	CcSEcCtD
Metformin—Abdominal pain—Paclitaxel—kidney cancer	8.79e-05	0.00051	CcSEcCtD
Metformin—Headache—Vincristine—kidney cancer	8.77e-05	0.000509	CcSEcCtD
Metformin—Hepatobiliary disease—Doxorubicin—kidney cancer	8.72e-05	0.000506	CcSEcCtD
Metformin—Anorexia—Capecitabine—kidney cancer	8.7e-05	0.000505	CcSEcCtD
Metformin—Hypotension—Capecitabine—kidney cancer	8.52e-05	0.000495	CcSEcCtD
Metformin—Vomiting—Gemcitabine—kidney cancer	8.44e-05	0.00049	CcSEcCtD
Metformin—Bradycardia—Doxorubicin—kidney cancer	8.43e-05	0.000489	CcSEcCtD
Metformin—Rash—Gemcitabine—kidney cancer	8.37e-05	0.000486	CcSEcCtD
Metformin—Dermatitis—Gemcitabine—kidney cancer	8.36e-05	0.000485	CcSEcCtD
Metformin—Headache—Gemcitabine—kidney cancer	8.32e-05	0.000483	CcSEcCtD
Metformin—Nausea—Vincristine—kidney cancer	8.31e-05	0.000483	CcSEcCtD
Metformin—Musculoskeletal discomfort—Capecitabine—kidney cancer	8.31e-05	0.000482	CcSEcCtD
Metformin—Rhinitis—Doxorubicin—kidney cancer	8.3e-05	0.000482	CcSEcCtD
Metformin—Hepatitis—Doxorubicin—kidney cancer	8.28e-05	0.00048	CcSEcCtD
Metformin—Hypoaesthesia—Doxorubicin—kidney cancer	8.23e-05	0.000478	CcSEcCtD
Metformin—Paraesthesia—Capecitabine—kidney cancer	8.19e-05	0.000475	CcSEcCtD
Metformin—Oedema peripheral—Doxorubicin—kidney cancer	8.15e-05	0.000473	CcSEcCtD
Metformin—Connective tissue disorder—Doxorubicin—kidney cancer	8.13e-05	0.000472	CcSEcCtD
Metformin—Dyspnoea—Capecitabine—kidney cancer	8.13e-05	0.000472	CcSEcCtD
Metformin—Dyspepsia—Capecitabine—kidney cancer	8.03e-05	0.000466	CcSEcCtD
Metformin—Asthenia—Paclitaxel—kidney cancer	7.98e-05	0.000463	CcSEcCtD
Metformin—Decreased appetite—Capecitabine—kidney cancer	7.93e-05	0.00046	CcSEcCtD
Metformin—Nausea—Gemcitabine—kidney cancer	7.89e-05	0.000458	CcSEcCtD
Metformin—Gastrointestinal disorder—Capecitabine—kidney cancer	7.88e-05	0.000457	CcSEcCtD
Metformin—Fatigue—Capecitabine—kidney cancer	7.86e-05	0.000457	CcSEcCtD
Metformin—Pruritus—Paclitaxel—kidney cancer	7.86e-05	0.000457	CcSEcCtD
Metformin—Constipation—Capecitabine—kidney cancer	7.8e-05	0.000453	CcSEcCtD
Metformin—Eye disorder—Doxorubicin—kidney cancer	7.73e-05	0.000449	CcSEcCtD
Metformin—Flushing—Doxorubicin—kidney cancer	7.68e-05	0.000446	CcSEcCtD
Metformin—Cardiac disorder—Doxorubicin—kidney cancer	7.68e-05	0.000446	CcSEcCtD
Metformin—Diarrhoea—Paclitaxel—kidney cancer	7.61e-05	0.000441	CcSEcCtD
Metformin—Feeling abnormal—Capecitabine—kidney cancer	7.52e-05	0.000436	CcSEcCtD
Metformin—Angiopathy—Doxorubicin—kidney cancer	7.51e-05	0.000436	CcSEcCtD
Metformin—Immune system disorder—Doxorubicin—kidney cancer	7.48e-05	0.000434	CcSEcCtD
Metformin—Gastrointestinal pain—Capecitabine—kidney cancer	7.46e-05	0.000433	CcSEcCtD
Metformin—Mediastinal disorder—Doxorubicin—kidney cancer	7.46e-05	0.000433	CcSEcCtD
Metformin—Chills—Doxorubicin—kidney cancer	7.43e-05	0.000431	CcSEcCtD
Metformin—Dizziness—Paclitaxel—kidney cancer	7.35e-05	0.000427	CcSEcCtD
Metformin—Urticaria—Capecitabine—kidney cancer	7.25e-05	0.000421	CcSEcCtD
Metformin—Abdominal pain—Capecitabine—kidney cancer	7.21e-05	0.000419	CcSEcCtD
Metformin—Erythema—Doxorubicin—kidney cancer	7.2e-05	0.000418	CcSEcCtD
Metformin—Malnutrition—Doxorubicin—kidney cancer	7.2e-05	0.000418	CcSEcCtD
Metformin—Flatulence—Doxorubicin—kidney cancer	7.1e-05	0.000412	CcSEcCtD
Metformin—Vomiting—Paclitaxel—kidney cancer	7.07e-05	0.00041	CcSEcCtD
Metformin—Dysgeusia—Doxorubicin—kidney cancer	7.06e-05	0.00041	CcSEcCtD
Metformin—Rash—Paclitaxel—kidney cancer	7.01e-05	0.000407	CcSEcCtD
Metformin—Dermatitis—Paclitaxel—kidney cancer	7e-05	0.000406	CcSEcCtD
Metformin—Headache—Paclitaxel—kidney cancer	6.96e-05	0.000404	CcSEcCtD
Metformin—Muscle spasms—Doxorubicin—kidney cancer	6.93e-05	0.000402	CcSEcCtD
Metformin—Vision blurred—Doxorubicin—kidney cancer	6.79e-05	0.000394	CcSEcCtD
Metformin—Ill-defined disorder—Doxorubicin—kidney cancer	6.68e-05	0.000388	CcSEcCtD
Metformin—Nausea—Paclitaxel—kidney cancer	6.6e-05	0.000383	CcSEcCtD
Metformin—Asthenia—Capecitabine—kidney cancer	6.54e-05	0.00038	CcSEcCtD
Metformin—Malaise—Doxorubicin—kidney cancer	6.5e-05	0.000377	CcSEcCtD
Metformin—Syncope—Doxorubicin—kidney cancer	6.46e-05	0.000375	CcSEcCtD
Metformin—Pruritus—Capecitabine—kidney cancer	6.45e-05	0.000375	CcSEcCtD
Metformin—Palpitations—Doxorubicin—kidney cancer	6.37e-05	0.00037	CcSEcCtD
Metformin—Loss of consciousness—Doxorubicin—kidney cancer	6.33e-05	0.000368	CcSEcCtD
Metformin—Diarrhoea—Capecitabine—kidney cancer	6.24e-05	0.000362	CcSEcCtD
Metformin—Hypertension—Doxorubicin—kidney cancer	6.22e-05	0.000361	CcSEcCtD
Metformin—Myalgia—Doxorubicin—kidney cancer	6.13e-05	0.000356	CcSEcCtD
Metformin—Chest pain—Doxorubicin—kidney cancer	6.13e-05	0.000356	CcSEcCtD
Metformin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	6.09e-05	0.000354	CcSEcCtD
Metformin—Discomfort—Doxorubicin—kidney cancer	6.06e-05	0.000352	CcSEcCtD
Metformin—Dizziness—Capecitabine—kidney cancer	6.03e-05	0.00035	CcSEcCtD
Metformin—Oedema—Doxorubicin—kidney cancer	5.88e-05	0.000341	CcSEcCtD
Metformin—Infection—Doxorubicin—kidney cancer	5.84e-05	0.000339	CcSEcCtD
Metformin—Vomiting—Capecitabine—kidney cancer	5.8e-05	0.000337	CcSEcCtD
Metformin—Shock—Doxorubicin—kidney cancer	5.79e-05	0.000336	CcSEcCtD
Metformin—Nervous system disorder—Doxorubicin—kidney cancer	5.77e-05	0.000335	CcSEcCtD
Metformin—Thrombocytopenia—Doxorubicin—kidney cancer	5.76e-05	0.000334	CcSEcCtD
Metformin—Rash—Capecitabine—kidney cancer	5.75e-05	0.000334	CcSEcCtD
Metformin—Dermatitis—Capecitabine—kidney cancer	5.75e-05	0.000334	CcSEcCtD
Metformin—Headache—Capecitabine—kidney cancer	5.71e-05	0.000332	CcSEcCtD
Metformin—Skin disorder—Doxorubicin—kidney cancer	5.71e-05	0.000332	CcSEcCtD
Metformin—Hyperhidrosis—Doxorubicin—kidney cancer	5.68e-05	0.00033	CcSEcCtD
Metformin—Anorexia—Doxorubicin—kidney cancer	5.6e-05	0.000325	CcSEcCtD
Metformin—Hypotension—Doxorubicin—kidney cancer	5.49e-05	0.000319	CcSEcCtD
Metformin—Nausea—Capecitabine—kidney cancer	5.42e-05	0.000315	CcSEcCtD
Metformin—Musculoskeletal discomfort—Doxorubicin—kidney cancer	5.36e-05	0.000311	CcSEcCtD
Metformin—Paraesthesia—Doxorubicin—kidney cancer	5.28e-05	0.000307	CcSEcCtD
Metformin—Dyspnoea—Doxorubicin—kidney cancer	5.24e-05	0.000304	CcSEcCtD
Metformin—Somnolence—Doxorubicin—kidney cancer	5.23e-05	0.000303	CcSEcCtD
Metformin—Dyspepsia—Doxorubicin—kidney cancer	5.18e-05	0.0003	CcSEcCtD
Metformin—Decreased appetite—Doxorubicin—kidney cancer	5.11e-05	0.000297	CcSEcCtD
Metformin—Gastrointestinal disorder—Doxorubicin—kidney cancer	5.08e-05	0.000295	CcSEcCtD
Metformin—Fatigue—Doxorubicin—kidney cancer	5.07e-05	0.000294	CcSEcCtD
Metformin—Constipation—Doxorubicin—kidney cancer	5.03e-05	0.000292	CcSEcCtD
Metformin—Feeling abnormal—Doxorubicin—kidney cancer	4.85e-05	0.000281	CcSEcCtD
Metformin—Gastrointestinal pain—Doxorubicin—kidney cancer	4.81e-05	0.000279	CcSEcCtD
Metformin—Urticaria—Doxorubicin—kidney cancer	4.67e-05	0.000271	CcSEcCtD
Metformin—Abdominal pain—Doxorubicin—kidney cancer	4.65e-05	0.00027	CcSEcCtD
Metformin—Asthenia—Doxorubicin—kidney cancer	4.22e-05	0.000245	CcSEcCtD
Metformin—Pruritus—Doxorubicin—kidney cancer	4.16e-05	0.000241	CcSEcCtD
Metformin—Diarrhoea—Doxorubicin—kidney cancer	4.02e-05	0.000234	CcSEcCtD
Metformin—Dizziness—Doxorubicin—kidney cancer	3.89e-05	0.000226	CcSEcCtD
Metformin—Vomiting—Doxorubicin—kidney cancer	3.74e-05	0.000217	CcSEcCtD
Metformin—Rash—Doxorubicin—kidney cancer	3.71e-05	0.000215	CcSEcCtD
Metformin—Dermatitis—Doxorubicin—kidney cancer	3.7e-05	0.000215	CcSEcCtD
Metformin—Headache—Doxorubicin—kidney cancer	3.68e-05	0.000214	CcSEcCtD
Metformin—Nausea—Doxorubicin—kidney cancer	3.49e-05	0.000203	CcSEcCtD
Metformin—NDUFA4—Metabolism—PTGS2—kidney cancer	1.26e-05	7.07e-05	CbGpPWpGaD
Metformin—NDUFB5—Metabolism—PTGS2—kidney cancer	1.26e-05	7.07e-05	CbGpPWpGaD
Metformin—NDUFA9—Metabolism—PTGS2—kidney cancer	1.26e-05	7.07e-05	CbGpPWpGaD
Metformin—NDUFB4—Metabolism—PTGS2—kidney cancer	1.26e-05	7.07e-05	CbGpPWpGaD
Metformin—NDUFV1—Metabolism—PTGS2—kidney cancer	1.26e-05	7.07e-05	CbGpPWpGaD
Metformin—ND3—Metabolism—PTGS2—kidney cancer	1.26e-05	7.07e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—CCBL1—kidney cancer	1.24e-05	6.97e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—PDHB—kidney cancer	1.23e-05	6.91e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—PSMD7—kidney cancer	1.21e-05	6.82e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—TSC1—kidney cancer	1.21e-05	6.82e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—ANXA1—kidney cancer	1.21e-05	6.82e-05	CbGpPWpGaD
Metformin—SLC47A1—Transmembrane transport of small molecules—RAF1—kidney cancer	1.21e-05	6.79e-05	CbGpPWpGaD
Metformin—NDUFS3—Metabolism—POMC—kidney cancer	1.19e-05	6.72e-05	CbGpPWpGaD
Metformin—NDUFS7—Metabolism—POMC—kidney cancer	1.19e-05	6.72e-05	CbGpPWpGaD
Metformin—NDUFC2—Metabolism—POMC—kidney cancer	1.19e-05	6.72e-05	CbGpPWpGaD
Metformin—ND1—Metabolism—GSTP1—kidney cancer	1.19e-05	6.66e-05	CbGpPWpGaD
Metformin—NDUFB3—Metabolism—PTEN—kidney cancer	1.18e-05	6.63e-05	CbGpPWpGaD
Metformin—NDUFA11—Metabolism—PTEN—kidney cancer	1.18e-05	6.63e-05	CbGpPWpGaD
Metformin—NDUFA12—Metabolism—PTEN—kidney cancer	1.18e-05	6.63e-05	CbGpPWpGaD
Metformin—NDUFA1—Metabolism—PTEN—kidney cancer	1.18e-05	6.63e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—FLT1—kidney cancer	1.17e-05	6.6e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—CCBL1—kidney cancer	1.16e-05	6.5e-05	CbGpPWpGaD
Metformin—SLC22A2—Transmission across Chemical Synapses—BRAF—kidney cancer	1.15e-05	6.47e-05	CbGpPWpGaD
Metformin—NDUFS2—Metabolism—POMC—kidney cancer	1.12e-05	6.31e-05	CbGpPWpGaD
Metformin—ND1—Metabolism—ABCB1—kidney cancer	1.12e-05	6.31e-05	CbGpPWpGaD
Metformin—NDUFV3—Metabolism—PTGS2—kidney cancer	1.12e-05	6.3e-05	CbGpPWpGaD
Metformin—SLC22A3—Transmembrane transport of small molecules—ABCB1—kidney cancer	1.12e-05	6.27e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—CA9—kidney cancer	1.11e-05	6.21e-05	CbGpPWpGaD
Metformin—NDUFAB1—Metabolism—PTEN—kidney cancer	1.1e-05	6.16e-05	CbGpPWpGaD
Metformin—NDUFA10—Metabolism—PTEN—kidney cancer	1.1e-05	6.16e-05	CbGpPWpGaD
Metformin—NDUFS6—Metabolism—PTEN—kidney cancer	1.1e-05	6.16e-05	CbGpPWpGaD
Metformin—NDUFA5—Metabolism—PTEN—kidney cancer	1.1e-05	6.16e-05	CbGpPWpGaD
Metformin—NDUFV2—Metabolism—PTEN—kidney cancer	1.1e-05	6.16e-05	CbGpPWpGaD
Metformin—ND4—Metabolism—PTEN—kidney cancer	1.1e-05	6.16e-05	CbGpPWpGaD
Metformin—ND5—Metabolism—PTEN—kidney cancer	1.1e-05	6.16e-05	CbGpPWpGaD
Metformin—NDUFA6—Metabolism—PTEN—kidney cancer	1.1e-05	6.16e-05	CbGpPWpGaD
Metformin—NDUFA13—Metabolism—PTEN—kidney cancer	1.1e-05	6.16e-05	CbGpPWpGaD
Metformin—NDUFB6—Metabolism—PTEN—kidney cancer	1.1e-05	6.16e-05	CbGpPWpGaD
Metformin—NDUFA3—Metabolism—PTEN—kidney cancer	1.1e-05	6.16e-05	CbGpPWpGaD
Metformin—ND4L—Metabolism—PTEN—kidney cancer	1.1e-05	6.16e-05	CbGpPWpGaD
Metformin—ND3—Metabolism—PTEN—kidney cancer	1.1e-05	6.16e-05	CbGpPWpGaD
Metformin—NDUFV1—Metabolism—PTEN—kidney cancer	1.1e-05	6.16e-05	CbGpPWpGaD
Metformin—ND2—Metabolism—PTEN—kidney cancer	1.1e-05	6.16e-05	CbGpPWpGaD
Metformin—NDUFA2—Metabolism—PTEN—kidney cancer	1.1e-05	6.16e-05	CbGpPWpGaD
Metformin—NDUFB8—Metabolism—PTEN—kidney cancer	1.1e-05	6.16e-05	CbGpPWpGaD
Metformin—NDUFA8—Metabolism—PTEN—kidney cancer	1.1e-05	6.16e-05	CbGpPWpGaD
Metformin—NDUFS5—Metabolism—PTEN—kidney cancer	1.1e-05	6.16e-05	CbGpPWpGaD
Metformin—NDUFB10—Metabolism—PTEN—kidney cancer	1.1e-05	6.16e-05	CbGpPWpGaD
Metformin—NDUFB7—Metabolism—PTEN—kidney cancer	1.1e-05	6.16e-05	CbGpPWpGaD
Metformin—NDUFA4—Metabolism—PTEN—kidney cancer	1.1e-05	6.16e-05	CbGpPWpGaD
Metformin—NDUFB5—Metabolism—PTEN—kidney cancer	1.1e-05	6.16e-05	CbGpPWpGaD
Metformin—NDUFS1—Metabolism—PTEN—kidney cancer	1.1e-05	6.16e-05	CbGpPWpGaD
Metformin—NDUFA7—Metabolism—PTEN—kidney cancer	1.1e-05	6.16e-05	CbGpPWpGaD
Metformin—NDUFB4—Metabolism—PTEN—kidney cancer	1.1e-05	6.16e-05	CbGpPWpGaD
Metformin—NDUFB1—Metabolism—PTEN—kidney cancer	1.1e-05	6.16e-05	CbGpPWpGaD
Metformin—NDUFS4—Metabolism—PTEN—kidney cancer	1.1e-05	6.16e-05	CbGpPWpGaD
Metformin—NDUFC1—Metabolism—PTEN—kidney cancer	1.1e-05	6.16e-05	CbGpPWpGaD
Metformin—NDUFS8—Metabolism—PTEN—kidney cancer	1.1e-05	6.16e-05	CbGpPWpGaD
Metformin—NDUFB9—Metabolism—PTEN—kidney cancer	1.1e-05	6.16e-05	CbGpPWpGaD
Metformin—NDUFB2—Metabolism—PTEN—kidney cancer	1.1e-05	6.16e-05	CbGpPWpGaD
Metformin—NDUFA9—Metabolism—PTEN—kidney cancer	1.1e-05	6.16e-05	CbGpPWpGaD
Metformin—ND6—Metabolism—PTEN—kidney cancer	1.1e-05	6.16e-05	CbGpPWpGaD
Metformin—ND1—Metabolism—GSTM1—kidney cancer	1.09e-05	6.12e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—JUNB—kidney cancer	1.09e-05	6.12e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—PAK1—kidney cancer	1.09e-05	6.12e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—GLIPR1—kidney cancer	1.08e-05	6.05e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—PPAT—kidney cancer	1.08e-05	6.05e-05	CbGpPWpGaD
Metformin—SLC22A1—Transmission across Chemical Synapses—BRAF—kidney cancer	1.07e-05	6.03e-05	CbGpPWpGaD
Metformin—ND1—Metabolism—CYP1A1—kidney cancer	1.03e-05	5.8e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—GLIPR1—kidney cancer	1e-05	5.64e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—PPAT—kidney cancer	1e-05	5.64e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—FH—kidney cancer	1e-05	5.62e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—APRT—kidney cancer	1e-05	5.62e-05	CbGpPWpGaD
Metformin—NDUFV3—Metabolism—PTEN—kidney cancer	9.77e-06	5.49e-05	CbGpPWpGaD
Metformin—SLC22A2—Transmission across Chemical Synapses—RAF1—kidney cancer	9.61e-06	5.4e-05	CbGpPWpGaD
Metformin—NDUFS3—Metabolism—PTGS2—kidney cancer	9.53e-06	5.36e-05	CbGpPWpGaD
Metformin—NDUFS7—Metabolism—PTGS2—kidney cancer	9.53e-06	5.36e-05	CbGpPWpGaD
Metformin—NDUFC2—Metabolism—PTGS2—kidney cancer	9.53e-06	5.36e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—GPC3—kidney cancer	9.4e-06	5.28e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—CRABP1—kidney cancer	9.4e-06	5.28e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—FH—kidney cancer	9.32e-06	5.24e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—APRT—kidney cancer	9.32e-06	5.24e-05	CbGpPWpGaD
Metformin—SLC22A2—Transmembrane transport of small molecules—SLC5A5—kidney cancer	9.18e-06	5.16e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—CA2—kidney cancer	9.15e-06	5.14e-05	CbGpPWpGaD
Metformin—NDUFB11—Metabolism—PIK3CA—kidney cancer	9.1e-06	5.11e-05	CbGpPWpGaD
Metformin—SLC22A1—Transmission across Chemical Synapses—RAF1—kidney cancer	8.96e-06	5.04e-05	CbGpPWpGaD
Metformin—NDUFS2—Metabolism—PTGS2—kidney cancer	8.96e-06	5.04e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—ALAD—kidney cancer	8.91e-06	5.01e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—IGF2—kidney cancer	8.9e-06	5e-05	CbGpPWpGaD
Metformin—SLC22A2—Transmembrane transport of small molecules—SLC2A1—kidney cancer	8.87e-06	4.98e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—CDKN2B—kidney cancer	8.86e-06	4.98e-05	CbGpPWpGaD
Metformin—SLC22A2—Neuronal System—BRAF—kidney cancer	8.82e-06	4.96e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—GPC3—kidney cancer	8.76e-06	4.93e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—ITPR2—kidney cancer	8.74e-06	4.91e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—ST3GAL2—kidney cancer	8.7e-06	4.89e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—IGF1R—kidney cancer	8.61e-06	4.84e-05	CbGpPWpGaD
Metformin—SLC22A1—Transmembrane transport of small molecules—SLC5A5—kidney cancer	8.56e-06	4.81e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—CA2—kidney cancer	8.53e-06	4.79e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—ALDH1A1—kidney cancer	8.5e-06	4.78e-05	CbGpPWpGaD
Metformin—NDUFA1—Metabolism—PIK3CA—kidney cancer	8.32e-06	4.68e-05	CbGpPWpGaD
Metformin—NDUFA12—Metabolism—PIK3CA—kidney cancer	8.32e-06	4.68e-05	CbGpPWpGaD
Metformin—NDUFB3—Metabolism—PIK3CA—kidney cancer	8.32e-06	4.68e-05	CbGpPWpGaD
Metformin—NDUFA11—Metabolism—PIK3CA—kidney cancer	8.32e-06	4.68e-05	CbGpPWpGaD
Metformin—NDUFC2—Metabolism—PTEN—kidney cancer	8.31e-06	4.67e-05	CbGpPWpGaD
Metformin—NDUFS3—Metabolism—PTEN—kidney cancer	8.31e-06	4.67e-05	CbGpPWpGaD
Metformin—NDUFS7—Metabolism—PTEN—kidney cancer	8.31e-06	4.67e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—ALAD—kidney cancer	8.31e-06	4.67e-05	CbGpPWpGaD
Metformin—SLC22A1—Transmembrane transport of small molecules—SLC2A1—kidney cancer	8.26e-06	4.64e-05	CbGpPWpGaD
Metformin—SLC22A1—Neuronal System—BRAF—kidney cancer	8.22e-06	4.62e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—PGK1—kidney cancer	8.15e-06	4.58e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—SLC5A3—kidney cancer	8.15e-06	4.58e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—ST3GAL2—kidney cancer	8.11e-06	4.56e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—LDHB—kidney cancer	8e-06	4.49e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—ACHE—kidney cancer	7.97e-06	4.48e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—GSTT1—kidney cancer	7.97e-06	4.48e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—ALDH1A1—kidney cancer	7.93e-06	4.45e-05	CbGpPWpGaD
Metformin—NDUFS2—Metabolism—PTEN—kidney cancer	7.81e-06	4.39e-05	CbGpPWpGaD
Metformin—NDUFB5—Metabolism—PIK3CA—kidney cancer	7.74e-06	4.35e-05	CbGpPWpGaD
Metformin—NDUFV1—Metabolism—PIK3CA—kidney cancer	7.74e-06	4.35e-05	CbGpPWpGaD
Metformin—NDUFC1—Metabolism—PIK3CA—kidney cancer	7.74e-06	4.35e-05	CbGpPWpGaD
Metformin—NDUFB9—Metabolism—PIK3CA—kidney cancer	7.74e-06	4.35e-05	CbGpPWpGaD
Metformin—NDUFB8—Metabolism—PIK3CA—kidney cancer	7.74e-06	4.35e-05	CbGpPWpGaD
Metformin—NDUFA8—Metabolism—PIK3CA—kidney cancer	7.74e-06	4.35e-05	CbGpPWpGaD
Metformin—NDUFS4—Metabolism—PIK3CA—kidney cancer	7.74e-06	4.35e-05	CbGpPWpGaD
Metformin—NDUFA5—Metabolism—PIK3CA—kidney cancer	7.74e-06	4.35e-05	CbGpPWpGaD
Metformin—NDUFA4—Metabolism—PIK3CA—kidney cancer	7.74e-06	4.35e-05	CbGpPWpGaD
Metformin—NDUFB6—Metabolism—PIK3CA—kidney cancer	7.74e-06	4.35e-05	CbGpPWpGaD
Metformin—NDUFA2—Metabolism—PIK3CA—kidney cancer	7.74e-06	4.35e-05	CbGpPWpGaD
Metformin—ND6—Metabolism—PIK3CA—kidney cancer	7.74e-06	4.35e-05	CbGpPWpGaD
Metformin—NDUFS1—Metabolism—PIK3CA—kidney cancer	7.74e-06	4.35e-05	CbGpPWpGaD
Metformin—NDUFS5—Metabolism—PIK3CA—kidney cancer	7.74e-06	4.35e-05	CbGpPWpGaD
Metformin—NDUFA9—Metabolism—PIK3CA—kidney cancer	7.74e-06	4.35e-05	CbGpPWpGaD
Metformin—ND3—Metabolism—PIK3CA—kidney cancer	7.74e-06	4.35e-05	CbGpPWpGaD
Metformin—NDUFB1—Metabolism—PIK3CA—kidney cancer	7.74e-06	4.35e-05	CbGpPWpGaD
Metformin—NDUFS8—Metabolism—PIK3CA—kidney cancer	7.74e-06	4.35e-05	CbGpPWpGaD
Metformin—ND2—Metabolism—PIK3CA—kidney cancer	7.74e-06	4.35e-05	CbGpPWpGaD
Metformin—NDUFA6—Metabolism—PIK3CA—kidney cancer	7.74e-06	4.35e-05	CbGpPWpGaD
Metformin—NDUFA3—Metabolism—PIK3CA—kidney cancer	7.74e-06	4.35e-05	CbGpPWpGaD
Metformin—ND4L—Metabolism—PIK3CA—kidney cancer	7.74e-06	4.35e-05	CbGpPWpGaD
Metformin—NDUFAB1—Metabolism—PIK3CA—kidney cancer	7.74e-06	4.35e-05	CbGpPWpGaD
Metformin—NDUFB7—Metabolism—PIK3CA—kidney cancer	7.74e-06	4.35e-05	CbGpPWpGaD
Metformin—ND5—Metabolism—PIK3CA—kidney cancer	7.74e-06	4.35e-05	CbGpPWpGaD
Metformin—NDUFS6—Metabolism—PIK3CA—kidney cancer	7.74e-06	4.35e-05	CbGpPWpGaD
Metformin—NDUFB10—Metabolism—PIK3CA—kidney cancer	7.74e-06	4.35e-05	CbGpPWpGaD
Metformin—NDUFA13—Metabolism—PIK3CA—kidney cancer	7.74e-06	4.35e-05	CbGpPWpGaD
Metformin—NDUFA10—Metabolism—PIK3CA—kidney cancer	7.74e-06	4.35e-05	CbGpPWpGaD
Metformin—NDUFB4—Metabolism—PIK3CA—kidney cancer	7.74e-06	4.35e-05	CbGpPWpGaD
Metformin—ND4—Metabolism—PIK3CA—kidney cancer	7.74e-06	4.35e-05	CbGpPWpGaD
Metformin—NDUFV2—Metabolism—PIK3CA—kidney cancer	7.74e-06	4.35e-05	CbGpPWpGaD
Metformin—NDUFA7—Metabolism—PIK3CA—kidney cancer	7.74e-06	4.35e-05	CbGpPWpGaD
Metformin—NDUFB2—Metabolism—PIK3CA—kidney cancer	7.74e-06	4.35e-05	CbGpPWpGaD
Metformin—ND1—Metabolism—POMC—kidney cancer	7.7e-06	4.33e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—PGK1—kidney cancer	7.6e-06	4.27e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—SLC5A3—kidney cancer	7.6e-06	4.27e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—SCARB1—kidney cancer	7.54e-06	4.24e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—PTGS1—kidney cancer	7.47e-06	4.2e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—LDHB—kidney cancer	7.45e-06	4.19e-05	CbGpPWpGaD
Metformin—SLC22A2—Neuronal System—RAF1—kidney cancer	7.37e-06	4.14e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—PSMD7—kidney cancer	7.32e-06	4.11e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—HIF1A—kidney cancer	7.08e-06	3.98e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—TSC2—kidney cancer	7.07e-06	3.97e-05	CbGpPWpGaD
Metformin—SLC22A2—Transmembrane transport of small molecules—ABCB1—kidney cancer	7e-06	3.93e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—BCHE—kidney cancer	6.94e-06	3.9e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—CA9—kidney cancer	6.93e-06	3.9e-05	CbGpPWpGaD
Metformin—NDUFV3—Metabolism—PIK3CA—kidney cancer	6.9e-06	3.88e-05	CbGpPWpGaD
Metformin—SLC22A1—Neuronal System—RAF1—kidney cancer	6.87e-06	3.86e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—SLC5A5—kidney cancer	6.86e-06	3.85e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—KDR—kidney cancer	6.78e-06	3.81e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—SLC2A1—kidney cancer	6.62e-06	3.72e-05	CbGpPWpGaD
Metformin—SLC22A2—Transmission across Chemical Synapses—MAPK1—kidney cancer	6.59e-06	3.71e-05	CbGpPWpGaD
Metformin—SLC22A1—Transmembrane transport of small molecules—ABCB1—kidney cancer	6.52e-06	3.67e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—CA9—kidney cancer	6.46e-06	3.63e-05	CbGpPWpGaD
Metformin—SLC22A3—Transmembrane transport of small molecules—RAF1—kidney cancer	6.31e-06	3.55e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—APC—kidney cancer	6.24e-06	3.51e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—KIT—kidney cancer	6.24e-06	3.51e-05	CbGpPWpGaD
Metformin—SLC22A1—Transmission across Chemical Synapses—MAPK1—kidney cancer	6.15e-06	3.45e-05	CbGpPWpGaD
Metformin—ND1—Metabolism—PTGS2—kidney cancer	6.14e-06	3.45e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—POMC—kidney cancer	5.94e-06	3.34e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—CRABP1—kidney cancer	5.89e-06	3.31e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—BRAF—kidney cancer	5.87e-06	3.3e-05	CbGpPWpGaD
Metformin—NDUFS7—Metabolism—PIK3CA—kidney cancer	5.86e-06	3.3e-05	CbGpPWpGaD
Metformin—NDUFS3—Metabolism—PIK3CA—kidney cancer	5.86e-06	3.3e-05	CbGpPWpGaD
Metformin—NDUFC2—Metabolism—PIK3CA—kidney cancer	5.86e-06	3.3e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—GSTP1—kidney cancer	5.52e-06	3.1e-05	CbGpPWpGaD
Metformin—NDUFS2—Metabolism—PIK3CA—kidney cancer	5.51e-06	3.1e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—CRABP1—kidney cancer	5.49e-06	3.09e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—ITPR2—kidney cancer	5.48e-06	3.08e-05	CbGpPWpGaD
Metformin—ND1—Metabolism—PTEN—kidney cancer	5.36e-06	3.01e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—ABCB1—kidney cancer	5.23e-06	2.94e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—ITPR2—kidney cancer	5.11e-06	2.87e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—GSTM1—kidney cancer	5.07e-06	2.85e-05	CbGpPWpGaD
Metformin—SLC22A2—Neuronal System—MAPK1—kidney cancer	5.05e-06	2.84e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—ACHE—kidney cancer	5e-06	2.81e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—GSTT1—kidney cancer	5e-06	2.81e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—RAF1—kidney cancer	4.9e-06	2.75e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—RELA—kidney cancer	4.88e-06	2.74e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—ERBB2—kidney cancer	4.85e-06	2.72e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—CYP1A1—kidney cancer	4.81e-06	2.7e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—MTOR—kidney cancer	4.78e-06	2.69e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—SCARB1—kidney cancer	4.73e-06	2.66e-05	CbGpPWpGaD
Metformin—SLC22A1—Neuronal System—MAPK1—kidney cancer	4.71e-06	2.65e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—PTGS1—kidney cancer	4.68e-06	2.63e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—ACHE—kidney cancer	4.66e-06	2.62e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—GSTT1—kidney cancer	4.66e-06	2.62e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—PSMD7—kidney cancer	4.59e-06	2.58e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—CDKN1B—kidney cancer	4.49e-06	2.52e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—SCARB1—kidney cancer	4.41e-06	2.48e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—IL2—kidney cancer	4.39e-06	2.47e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—PTGS1—kidney cancer	4.36e-06	2.45e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—BCHE—kidney cancer	4.35e-06	2.45e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—SLC5A5—kidney cancer	4.3e-06	2.42e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—CCND1—kidney cancer	4.28e-06	2.41e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—PSMD7—kidney cancer	4.28e-06	2.41e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—JUN—kidney cancer	4.27e-06	2.4e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—CTNNB1—kidney cancer	4.24e-06	2.38e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—SLC2A1—kidney cancer	4.15e-06	2.33e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—PTEN—kidney cancer	4.13e-06	2.32e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—BCHE—kidney cancer	4.06e-06	2.28e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—SLC5A5—kidney cancer	4.01e-06	2.25e-05	CbGpPWpGaD
Metformin—SLC22A2—Transmembrane transport of small molecules—RAF1—kidney cancer	3.96e-06	2.23e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—SLC2A1—kidney cancer	3.87e-06	2.18e-05	CbGpPWpGaD
Metformin—ND1—Metabolism—PIK3CA—kidney cancer	3.78e-06	2.12e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—VEGFA—kidney cancer	3.73e-06	2.1e-05	CbGpPWpGaD
Metformin—SLC22A1—Transmembrane transport of small molecules—RAF1—kidney cancer	3.69e-06	2.07e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—POMC—kidney cancer	3.59e-06	2.02e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—MAPK3—kidney cancer	3.53e-06	1.98e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—GSTP1—kidney cancer	3.46e-06	1.95e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—MYC—kidney cancer	3.43e-06	1.93e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—MAPK1—kidney cancer	3.36e-06	1.89e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—ABCB1—kidney cancer	3.28e-06	1.84e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—GSTP1—kidney cancer	3.23e-06	1.81e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—GSTM1—kidney cancer	3.18e-06	1.79e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—KRAS—kidney cancer	3.17e-06	1.78e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—ABCB1—kidney cancer	3.06e-06	1.72e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—CYP1A1—kidney cancer	3.02e-06	1.7e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—GSTM1—kidney cancer	2.97e-06	1.67e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—PIK3CA—kidney cancer	2.92e-06	1.64e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—PTGS2—kidney cancer	2.86e-06	1.61e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—TP53—kidney cancer	2.82e-06	1.59e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—CYP1A1—kidney cancer	2.81e-06	1.58e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—PTEN—kidney cancer	2.5e-06	1.4e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—POMC—kidney cancer	2.25e-06	1.26e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—POMC—kidney cancer	2.1e-06	1.18e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—PTGS2—kidney cancer	1.79e-06	1.01e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—PIK3CA—kidney cancer	1.76e-06	9.89e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—PTGS2—kidney cancer	1.67e-06	9.4e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—PTEN—kidney cancer	1.56e-06	8.8e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—PTEN—kidney cancer	1.46e-06	8.2e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—PIK3CA—kidney cancer	1.1e-06	6.2e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—PIK3CA—kidney cancer	1.03e-06	5.78e-06	CbGpPWpGaD
